The recruitment of subjects stratified by insulin sensitivity allowed us to uniquely examine the combined effects of obesity and insulin resistance on glucagon, GLP-1, and GIP secretion, which has not been previously characterized in pediatric studies. The gene discussed is INS; the disease is Insulin resistance.